Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
Amy Knudsen, PhD
Senior Scientist, Institute for Technology Assessment


Amy received a BS with Distinction in policy analysis from Cornell University and a PhD in Health Policy from Harvard University.  While at Harvard, Amy was the recipient of a Cancer Prevention Training Grant from the National Cancer Institute (NCI) and a Dissertation Completion Fellowship from Harvard University.  She completed a NCI-funded post-doctoral fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training (PCORT).  She has worked for health-economics consulting firms where she developed decision-analytic models to assess the lifetime health and economic consequences of obesity and the benefits of weight loss.


 


Amy\'s research interests involve the use of disease simulation modeling to address cancer control policies.  She is developing a population-based colorectal cancer policy model that can be used to predict trends in colorectal cancer incidence and mortality under alternative scenarios for screening and treatment, as well as evaluate the cost-effectiveness of those interventions.


Back